Methodological issues in trials of complementary and alternative medicine interventions

Nursing Research

Volumn 58, Issue 6, 2009, Pages 444-451

  Sikorskii, Alla ^a   Wyatt, Gwen ^b   Victorson, David ^c   Faulkner, Gwen ^d   Rahbar, Mohammad Hossein ^e  

^a Texas Institute for Discovery Education in Science   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

Complementary and alternative therapies; Methodology

Indexed keywords

ALTERNATIVE MEDICINE; ARTICLE; METHODOLOGY; NURSING; RANDOMIZED CONTROLLED TRIAL (TOPIC);

COMPLEMENTARY THERAPIES; NURSING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 73549084728     PISSN: 00296562     EISSN: None     Source Type: Journal    
DOI: 10.1097/NNR.0b013e3181bf15fe     Document Type: Article

References (42)

1. Altman, D. G., & Bland, J. M. (1995). Absence of evidence is not evidence of absence. BMJ, 311(7003), 485.
2. Altman, D. G., Schultz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., et al. (2001). The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Annals of Internal Medicine, 134(8), 663-694. (Pubitemid 32322245)
3. American Nurses Association & American HolisticNurses Association. (2007). Holistic nursing: Scope and standards of practice. Silver Springs, MD: Author.
4. American Society of Clinical Oncology. (2001). Quality of life: Symptom management an essential component of cancer care [Electronic version]. Retrieved December 31, 2008, from www.asco.org.
5. Angell, M., & Kassirer, J. P. (1998). Alternative medicineVThe risks of untested and unregulated remedies. New England Journal of Medicine, 339, 839-841.
6. Astin, J. A. (1998). Why patients use alternative medicine: Results of a national study. Journal of the American Medical Association, 279, 1548-1553.
7. Begg, C., Cho, M., Eastwood, S., Horton, R., Mher, D., Olkin, I., et al. (1996). Improving quality of reporting of randomized controlled trials. The CONSORT statement. Journal of the American Medical Association, 276, 637-639.
8. Boon, H. S., Olatunde, F., & Zick, S. M. (2007). Trends in complementary/ alternative medicine use by breast cancer survivors: Comparing survey data from 1998 and 2005. BMC Women's Health, 7, 4-10.
9. Buchanan, D. R., White, J. D., O'Mara, A. M., Kelaghan, J. W., Smith, W. B., & Minasian, L. M. (2005). Research-design issues in cancer-symptom- management trials using complementary and alternative medicine: Lessons from the National Cancer Institute Community Clinical Oncology Program experience. Journal of Clinical Oncology, 23, 6682-6689.
10. Byers, D. (1996). Better health with foot reflexology: The original Ingham Method. St. Petersburg: Ingham Publishing, Inc.
11. Campagnaro, E., Saliba, R., Giralt, S., Roden, L., Medoza, F., Aleman, A., et al. (2008). Symptom burden after autologous stem cell transplantation for multiple myeloma. Cancer, 112, 1617-1624.
12. Cassileth, B. R., & Vickers, A. J. (2005). High prevalence of complementary and alternative medicine use among cancer patients: Implications for research and clinical care. Journal of Clinical Oncology, 23, 2590-2592.
13. Cella, D. F., Hahn, E. A., & Dineen, K. (2002). Meaningful change in cancerspecific quality of life scores: Differences between improvement and worsening. Quality of Life Research, 11, 207-221.
14. Chao, M. T., Wade, C., & Kronenberg, F. (2008). Disclosure of complementary and alternative medicine to conventional medical providers: Variation by race/ethnicity and type of CAM. Journal of the National Medical Association, 100, 1341-1349.
15. Cleeland, C. S. (2007). Symptom burden: Multiple symptoms and their impact as patient-reported outcomes. Journal of the National Cancer Institute. Monographs, 16-21.
16. Dodd, M. J., Miaskowski, C., & Paul, S. M. (2001). Symptom clusters and their effect on the functional status of patients with cancer. Oncology Nursing Forum, 28, 465-470.
17. Efficace, F., Horneber, M., Lejeune, S., Van Dam, F., Leering, S., Rottmann, M., et al. (2006). Methodological quality of patient-reported outcome research was low in complementary and alternative medicine in oncology. Journal of Clinical Epidemiology, 59, 1257-1265.
18. Eisenberg, D. M., Daves, R. B., Ettner, S. L., Appel, S., Wilkey, S., Van Rompay, M., et al. (1998). Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national study. Journal of the American Medical Association, 280, 1569-1575.
19. Ernst, E., Schmidt, K., & Baum, M. (2006). Complementary/alternative therapies for the treatment of breast cancer. A systematic review of randomized clinical trials and a critique of current terminology. Breast Journal, 12, 526-530.
20. Ernst, E., & White, A. (2000). The BBC survey of complementary medicine use in the UK. Complementary Therapies in Medicine, 8, 32-36.
21. Given, C. W., Given, B., Azzouz, F., Kozachik, S., & Stommel, M. (2001). Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients. Journal of Pain and Symptom Management, 21(6), 456-466. (Pubitemid 32492931)
22. Jatoi, A., Kumar, S., Sloan, J. A., & Nguyen, P. L. (2003). On appetite and its loss. Journal of Clinical Oncology, 21, 79s-81s.
23. MacLennan, A. H., Wilson, D. H., & Taylor, A. W. (2002). The escalating cost and prevalence of alternative medicine. Preventive Medicine, 35, 166-173.
24. Mendoza, T. R., Wang, X. S., Cleeland, C. S., Morrissey, M., Johnson, B. A., Wendt, J. K., et al. (1999). The rapid assessment of fatigue severity in cancer patients: Use of the Brief Fatigue Inventory. Cancer, 85, 1186-1196.
25. Oleson, T., & Flocco, W. (1993). Randomized control study of premenstrual symptoms treated with ear, hand, and foot reflexology. Obstetrics and Gynecology, 82(6), 906-911.
26. Pagan, J. A., & Pauly, M. V. (2005). Access to conventional medical care and the use of complementary and alternative medicine. Health Affairs, 24, 255-262.
27. Punt, C. J., Buyse, M., Kohne, C. H., Hohenberger, P., Labianca, R., Schmoll, H. J., et al. (2007). Endpoints in adjuvant treatment trials: A systematic review of the literature in colon cancer and proposed definitions for future trials. Journal of the National Cancer Institute, 99, 998-1003.
28. Richardson, M. A., Sanders, T., Palmer, J. L., Greisinger, A., & Singletary, S. E. (2000). Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. Journal of Clinical Oncology, 18, 2505-2514.
29. Santacroce, S. J., Maccarelli, L. M., & Grey, M. (2004). Intervention fidelity. Nursing Research, 53(1), 63-66.
30. Senn, S. (2007). Statistical issues in drug development (2nd ed.). Chichester: John Wily & Sons.
31. Sikorskii, A., Given, C., You, M., Jeon, S., & Given, B. (2009). Response analysis for multiple symptoms revealed differences between arms of a symptom management trial. Journal of Clinical Epidemiology 62(7), 716-724.
32. Sikorskii, A., Wyatt, G., Siddiqi, A., & Tamkus, D. (in press). Recruitment and early retention of women with advanced breast cancer in a complementary and alternative medicine (CAM) trial. Evidence-Based Complementary and Alternative Medicine.
33. Sloan, J. A., Berk, L., Roscoe, J., Fisch, M. J., Shaw, E. G., Wyatt, G., et al. (2007). Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. Journal of Clinical Oncology, 25, 5070-5077.
34. Stephenson, N. L., Weinrich, S. P., & Tavakoli, A. S. (2000). The effects of foot reflexology on anxiety and pain in patients with breast and lung cancer. Oncology Nursing Forum, 27, 67-72.
35. Taves, D. R. (1974). Minimization: A new method of assigning patients to treatment and control groups. Clinical Pharmacology and Therapeutics, 15, 443-453.
36. Tindle, H. A., Davis, R. B., Phillips, R. S., & Eisenberg, D. M. (2005). Trends in use of complementary and alternative medicine by US adults: 1997-2002. Alternative Therapies in Health and Medicine, 11, 42-49.
37. Washington, DC: Author Services. (2006). Guidance for industry. Patient-reported outcome measures: Use in medical product development to support labeling claims (draft guidance). Washington, DC: Author.
38. Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. Journal of the American Medical Association, 273, 59-65.
39. Wyatt, G., Sikorskii, A., Siddiqi, A., & Given, C. W. (2007). Feasibility of a reflexology and guided imagery intervention during chemotherapy: Results of a quasi-experimental study. Oncology Nursing Forum, 34, 635-642.
40. Zelman, D., Smith, M., & Miaskowski, C. (2005). Categorizing the severity of cancer pain: Further exploration of the established cutpoints. Pain, 113, 37-44.
41. Zick, S. M., Ruffin,M. T., Lee, J., Normolle, D. P., Siden, R., Alrawi, S., et al. (2009). Phase II trial of encapsulating ginger as a treatment for a chemotherapy-induced nausea and vomiting. Support Care in Cancer, 17(5), 563-572.
42. Ziegler, R. (2009). Mistletoe preparation iscador: Are the methodological concerns with respect to controlled clinical trials? Evidence-Based Complementary and Alternative Medicine, 6(1), 19-30.